Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
Oil Companies Still Making Piles of Money
by The Investment U Research Team
It’s not without some sort of satisfaction that many consumers react to the news that earning reports from oil companies have been dismal. After all, these companies have been making money off us hand over fist for quite some time.
Of course that doesn’t mean that they aren’t still making money.
Exxon Mobil (NYSE: XOM) reported that profit dropped 66% last quarter. Although it still made $3.95 billion, it’s just not making money hand over fist like last year.
In a eerily similar report, Royal Dutch Shell ADR (NYSE: RDS.A) said that it’s profit dropped 67% to $3.82 billion. ConocoPhillips (NYSE: COP) fared even worse, with profits plummeting 76% to $1.3 billion.
Hard times indeed in the petroleum industry.
This all comes on the heels of a volatile market in oil prices, regulators considering limits on oil speculation, and oil stockpiles fluctuating.
The real reason oil supplies have been moving so much is the contango situation that caused millions of barrels of oil to be stored offshore in tankers. As the capacity has opened up some of this oil is migrating ashore – but not much.
This is skewing the supply numbers up and down depending upon the pricing and motivations of the sellers.
Oil is opening up at almost $67 a barrel today, and it’s easy to see how supply and demand pressures will keep that fluctuating for a good deal into the future.
Symbols mentioned in this article: XOM, RDS.A, COP.
- How To Play the Oil Conspiracy Theories
- Contango: The Most Profitable “Buy-and-Hold” for 2009
- As the Oil Contango Unwinds… Here’s How To Profit From Shipping Rates
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed